Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biovica International AB (publ)
  6. News
  7. Summary
    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biovica International : Nomination Committee for Biovica for the 2021 Annual General Meeting

02/26/2021 | 02:01am EDT

The Nomination Committee prior to the 2021 Annual General Meeting will consist of three members, who shall represent the two shareholders with the most number of shares who accept the assignment to be part of the Nomination Committee as of December 31, 2020, and the Chairman of the Board. The Nomination Committee then appoints a chairman among its members.

In accordance with the above guidelines, the Nomination Committee for the 2021 Annual General Meeting will consist of the following persons:

  • Anna Rylander Eklund, chair of the nomination committee, appointed by the Rylander family
  • Mikael Petersson, appointed by Coeli
  • Lars Holmqvist, Chairman of the Board

The members of the Nomination Committee together represent approximately 25 percent of the shares and 39 percent of the votes in the company as of December 31, 2020.

The Nomination Committee's overall responsibility is to submit proposals regarding the Chairman at the Annual General Meeting, election and remuneration of Board members, election and remuneration of the auditor, as well as principles for the appointment of the Nomination Committee and instructions for the Nomination Committee.

Shareholders who wish to submit proposals to the company's nomination committee can do so via e-mail to ir@biovica.com or by letter to the address: Biovica International AB, Att: The Nomination Committee, Dag Hammarskjölds väg 54B, 752 37 Uppsala.

The Annual General Meeting of Biovica International AB will be held on Tuesday, August 31, 2021 in Uppsala.

© Modular Finance, source Nordic Press Releases

All news about BIOVICA INTERNATIONAL AB (PUBL)
09/23BIOVICA INTERNATIONAL : Notice of extra general meeting in Biovica International AB
AQ
09/20BIOVICA INTERNATIONAL AB(OM : BIOVIC B) added to S&P Global BMI Index
CI
09/15BIOVICA INTERNATIONAL : DiviTum«TKa results from SWOG study published in Clinical Cancer R..
AQ
09/15Biovica Announces DiviTum«TKa results from SWOG study published in Clinical Cancer Rese..
CI
09/14BIOVICA INTERNATIONAL : Promising DiviTumTKa results from BioItaLEE study presented at ESM..
AQ
09/13BIOVICA INTERNATIONA : Biovica International
AQ
09/13BIOVICA INTERNATIONAL : provides update on FDA application process
AQ
09/13Biovica International AB Provides Update on FDA Application Process
CI
08/31BIOVICA INTERNATIONAL : Announcement from Biovica International's annual general meeting
AQ
08/31BIOVICA INTERNATIONAL : DiviTum«TKa approaching FDA approval
AQ
More news
Financials
Sales 2022 48,6 M 5,62 M 5,62 M
Net income 2022 -32,6 M -3,76 M -3,76 M
Net cash 2022 252 M 29,1 M 29,1 M
P/E ratio 2022 -52,9x
Yield 2022 -
Capitalization 1 518 M 175 M 175 M
EV / Sales 2022 26,0x
EV / Sales 2023 8,34x
Nbr of Employees 20
Free-Float 41,9%
Chart BIOVICA INTERNATIONAL AB (PUBL)
Duration : Period :
Biovica International AB (publ) Technical Analysis Chart | BIOVIC B | SE0008613731 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 53,40 SEK
Average target price 103,00 SEK
Spread / Average Target 92,9%
EPS Revisions
Managers and Directors
Anders Rylander Chief Executive Officer & Director
Cecilia Driving CFO, Head-Human Resource, IR & EVP
Lars Erik Holmqvist Chairman
Mattias Bergqvist Director-Clinical Development
Otti Bengtsson Gref Director-Research & Development
Sector and Competitors